Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Neuroleptic-induced Movement Disorders: A Comprehensive Survey > 11 - Neurochemistry of the basal ganglia
Neuroleptic-induced Movement Disorders: A Comprehensive Survey |
Ramzy Yassa; N. P. V. Nair; Dilip V. Jeste
Cambridge University Press
Neuroleptic-induced Movement Disorders: A Comprehensive Survey
11 - Neurochemistry of the basal ganglia
Authors

N. P. V. Nair, M.D.; T. E. G. West, Ph.D.

ARI Id

1667206028339_10126765

Access

Not Available Free

Pages

129-140

Chapter URL

https://www.cambridge.org/core/books/neurolepticinduced-movement-disorders/neurochemistry-of-the-basal-ganglia/2D4EE191F11DE9E93D8F5D00E97440A1

Table of Contents of Book
Showing 1 to 20 of 42 entries
Chapters/HeadingsAuthor(s)PagesInfo
Frontmatter
i-iv
Contents
v-viii
Contributors
ix-xiv
Preface
xv-xviii
Part I - Historical perspective
1-2
1 - Neuroleptic-induced movement disorders: historical perspective
Marc-Alain Wolf, M.D.; Ramzy Yassa, M.D.; Pierre-Michel Llorca, M.D.
3-10
Part II - Clinical aspects of tardive dyskinesia
11-12
2 - Aging and tardive dyskinesia
Bruce L. Saltz, M.D.; John M. Kane, M.D.; Margaret G. Woerner, Ph.D.; Jeffrey A. Lieberman, M.D.; José MA. J. Alvir, Dr. P.H.
13-25
3 - Gender as a factor in the development of tardive dyskinesia
Ramzy Yassa, M.D.; Dilip V. Jeste, M.D.
26-40
4 - The Yale tardive dyskinesia study: a prospective incidence study among long-term outpatients
William M. Glazer, M.D.; Hal Morgenstern, Ph.D.; Donna Raye Wagner, M.A.; John Doucette, M.Phil.
41-55
5 - Vulnerability to tardive dyskinesia in schizophrenia: an exploration of individual patient factors
John L. Waddington, Ph.D.; Eadbhard O'; Callaghan, F.R.C.P.I.; Peter Buckley, M.R.C.Psych.; Cathy Madigan, M.A.; Conall Larkin, F.R.C.Psych.; Anthony Kinsella, M.Sc.
56-68
6 - Tardive dyskinesia and affective disorder
George Gardos, M.D.; Jonathan O. Cole, M.D.
69-81
7 - Diabetes mellitus and tardive dyskinesia
Sukdeb Mukherjee, M.D.; Sahebarao P. Mahadik, Ph.D.
82-98
8 - Other factors in the development of tardive dyskinesia
Ramzy Yassa, M.D.
99-103
9 - Neuroleptic treatment and tardive dyskinesia
George Gardos, M.D.; Jonathan O. Cole, M.D.
104-116
10 - Anticholinergic drugs as factors in the development of tardive dyskinesia
Ramzy Yassa, M.D.; N. P. V. Nair, M.D.
117-126
Part III - Mechanisms underlying tardive dyskinesia
127-128
11 - Neurochemistry of the basal ganglia
N. P. V. Nair, M.D.; T. E. G. West, Ph.D.
129-140
12 - A reanalysis of the dopamine theory of tardive dyskinesia: the hypothesis of dopamine D1/D2 imbalance
Linda Peacock, M. D.; Jes Gerlach, M.D.
141-160
13 - Tardive dyskinesia and phenylalanine metabolism: risk-factor studies
Mary Ann Richardson, Ph.D.; Cheryl Flynn, Ph.D.; Laura Read, Ph.D.; Margaret Reilly, Ph.D.; Raymond Suckow, Ph.D.
161-174
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 42 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings